The launch of these subsidiaries is a strategic expansion for Elevai Labs, indicating a focused effort to diversify and strengthen its presence in the biosciences and skincare industries. This move could attract investor interest due to the potential for new product developments and market penetration, likely leading to a positive short-term impact on ELAB's stock price.